- Home
- BCRX vs PTEN Comparison
BCRX vs PTEN Comparison
Compare BCRX & PTEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCRX
- PTEN
- Stock Information
- Founded
- BCRX 1986
- PTEN 1978
- Country
- BCRX United States
- PTEN United States
- Employees
- BCRX N/A
- PTEN N/A
- Industry
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- PTEN Oil & Gas Production
- Sector
- BCRX Health Care
- PTEN Energy
- Exchange
- BCRX Nasdaq
- PTEN Nasdaq
- Market Cap
- BCRX 1.8B
- PTEN 2.1B
- IPO Year
- BCRX 1994
- PTEN 1993
- Fundamental
- Price
- BCRX $8.27
- PTEN $5.67
- Analyst Decision
- BCRX Strong Buy
- PTEN Buy
- Analyst Count
- BCRX 10
- PTEN 10
- Target Price
- BCRX $16.70
- PTEN $7.90
- AVG Volume (30 Days)
- BCRX 2.3M
- PTEN 7.7M
- Earning Date
- BCRX 11-03-2025
- PTEN 10-22-2025
- Dividend Yield
- BCRX N/A
- PTEN 5.64%
- EPS Growth
- BCRX N/A
- PTEN N/A
- EPS
- BCRX N/A
- PTEN N/A
- Revenue
- BCRX $557,506,000.00
- PTEN $5,019,214,000.00
- Revenue This Year
- BCRX $41.37
- PTEN N/A
- Revenue Next Year
- BCRX $7.56
- PTEN N/A
- P/E Ratio
- BCRX N/A
- PTEN N/A
- Revenue Growth
- BCRX 45.85
- PTEN N/A
- 52 Week Low
- BCRX $6.02
- PTEN $5.12
- 52 Week High
- BCRX $11.31
- PTEN $9.58
- Technical
- Relative Strength Index (RSI)
- BCRX 43.55
- PTEN 49.35
- Support Level
- BCRX $8.02
- PTEN $5.41
- Resistance Level
- BCRX $8.68
- PTEN $5.88
- Average True Range (ATR)
- BCRX 0.22
- PTEN 0.22
- MACD
- BCRX 0.01
- PTEN 0.04
- Stochastic Oscillator
- BCRX 37.88
- PTEN 69.12
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About PTEN Patterson-UTI Energy Inc.
Patterson-UTI Energy Inc is one of the substantial land rig drilling contractors in the United States. Its 2023 merger with NexTier greatly expanded its pressure pumping operations, as well, and the firm now controls nearly 20% of the North American market for drilling and completions services. The company operates under three reportable business segments: (i) drilling services, (ii) completion services, and (iii) drilling products. It also provides directional drilling services and tool rental services in united states onshore oil and gas basins.